Expertise in
8
conditions

Peter Youssef

Sydney, NSW, AU 
Expertise in
8
conditions
Sydney, NSW, AU 

Overview

Peter Youssef practices practicing medicine in Sydney, Australia.

Mr. Youssef is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Interstitial Lung Disease, and Acute Interstitial Pneumonia.

He is actively involved in clinical research, co-authoring 45 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Sydney, NSW 2050, Australia
Other Locations
Camperdown, NSW, Australia
Camperdown, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 2 Less Clinical Trials

45 Total Publications

Intravenous injection of lipid-free apolipoprotein A-I dampens inflammation by reprogramming macrophage function.
Intravenous injection of lipid-free apolipoprotein A-I dampens inflammation by reprogramming macrophage function.
Journal: Cell reports
Published: November 14, 2025

Frequently Asked Questions about Peter Youssef

Is Peter Youssef a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Peter Youssef is classified as an Advanced expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peter Youssef participate in research or clinical trials?

Yes. Peter Youssef has published 45 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Peter Youssef's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Youssef's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile